ADVA
20.5.2021 09:02:13 CEST | Business Wire | Press release
ADVA (FSE: ADV) today launched its new compact, low-power edge demarcation solution, giving network operators an easy and cost-efficient route to 10Gbit/s Carrier Ethernet services. The ADVA FSP 150-XG108 Series meets the precise needs of mobile network operators (MNOs) aiming to deliver a faster and more responsive experience by rolling out 5G New Radio equipment at scale. The solution also enables enterprises to affordably extend bandwidth as they push data to the cloud and supports the cost-effective expansion of digitized cable networks. Featuring zero-touch provisioning and 5G timing capabilities, the ADVA FSP 150-XG108 Series is ideal for growing network capacity while reducing footprint, power and cost.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210520005061/en/
“Today’s MNOs need to be able to seize new revenue opportunities and grow capacity without worrying about increased energy consumption or rack space eating into profitability. That’s where our FSP 150-XG108 Series hits the sweet spot. It provides a quick and seamless way to deploy high-bandwidth Carrier Ethernet services without major cost,” said Christoph Glingener, CTO, ADVA. “Our FSP 150-XG108 Series is engineered for the practical challenges of meeting cloud and 5G demand. It consumes very little power and supports both 1Gbit/s and 10Gbit/s interface speeds in a 1RU footprint. What’s more, with its temperature-hardened design, our FSP 150-XG108 Series removes the need for expensive air-conditioning.”
The ADVA FSP 150-XG108 Series enables network operators to easily and affordably migrate from 1Gbit/s to 10Gbit/s MEF 3.0 services. Using proven and established OAM processes, it offers simple operation and network integration. With zero-touch provisioning, the ADVA FSP 150-XG108 Series removes the need for technically trained onsite staff and makes service activation quick and easy. Its compact design caters for space-restricted applications and its redundant power supply ensures high availability. The ADVA FSP 150-XG108 Series is also well prepared for emerging timing requirements with hardware-assisted BITS, PTP and SyncE synchronization.
“We’re providing the compact, robust and reliable demarcation that mobile, cable and enterprise networks require for massive 10Gbit/s rollout. Our FSP 150-XG108 Series is simple, efficient and highly scalable. With zero-touch provisioning, service activation becomes effortless. The FSP 150-XG108 Series also offers intuitive network control and service monitoring through the automated management of our Ensemble Controller and Ensemble Packet Director,” commented James Buchanan, GM, Edge Cloud, ADVA. “And, despite being optimized for cost-sensitive, high-bandwidth applications, our FSP 150-XG108 Series doesn’t compromise on performance or synchronization. It’s the perfect choice for empowering any network edge with 10Gbit/s demarcation and aggregation.”
Watch this product video for more information: https://youtu.be/pAcqPOtO5eI .
Additional details are also available in this Tech Cam interview: https://youtu.be/bdd-AqvgpBM .
Supporting slides can be viewed here: https://adva.li/fsp-150-xg108-series-slides .
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
Published by:
ADVA Optical Networking SE, Munich, Germany
View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005061/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom